Overview

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

This is a monocentric, randomized, opened study to assess the anti-inflammatory and anti-platelet effect of Clopidogrel and aspirin versus aspirin or clopidogrel alone in patients with symptomatic polyvascular disease and with multiple recurrent cardiovascular events.

Phase:

Phase 3

Details

Lead Sponsor:

Catholic University of the Sacred Heart

Treatments:

Aspirin
Clopidogrel
Ticlopidine